CN102716340B - Traditional Chinese medicine used for treating esophageal cancer - Google Patents

Traditional Chinese medicine used for treating esophageal cancer Download PDF

Info

Publication number
CN102716340B
CN102716340B CN201210231819.XA CN201210231819A CN102716340B CN 102716340 B CN102716340 B CN 102716340B CN 201210231819 A CN201210231819 A CN 201210231819A CN 102716340 B CN102716340 B CN 102716340B
Authority
CN
China
Prior art keywords
parts
weight
chinese medicine
traditional chinese
esophageal cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210231819.XA
Other languages
Chinese (zh)
Other versions
CN102716340A (en
Inventor
许瑞琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiang Fei
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210231819.XA priority Critical patent/CN102716340B/en
Publication of CN102716340A publication Critical patent/CN102716340A/en
Application granted granted Critical
Publication of CN102716340B publication Critical patent/CN102716340B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicines and particularly relates to a traditional Chinese medicine used for treating esophageal cancer. The traditional Chinese medicine used for treating the esophageal cancer is prepared from the following medicines in parts by weight: 6-9 parts of impatiens balsamina, 0.5-1.5 parts of Chinese blister beetle, 5-15 parts of pinellia ternate, 15-25 parts of poria cocos, 15-25 parts of dendrobe and 5-15 parts of liquorice. The traditional Chinese medicine used for treating the esophageal cancer has the effects of clearing heat and removing toxicity, softening hardness and transforming phlegm and harmonizing stomach and lowering adverse qi.

Description

A kind of Chinese medicine that is used for the treatment of the esophageal carcinoma
Technical field:
The invention belongs to the field of Chinese medicines, particularly a kind of Chinese medicine for the treatment of the esophageal carcinoma.
Background technology:
The esophageal carcinoma means the malignant change being formed by esophageal squamous cell columnar epithelium or epithelioglandular paraplasm.Its development is general through stages such as epithelial dysplasia, cancer in situ, infiltrating carcinomas.Esophagus squamous atypical hyperplasia is the important precancerous lesion of the esophageal carcinoma, generally needs several years more than ten years even by atypical hyperplasia to canceration.Just because of this, some esophageal carcinoma can also can be cured completely in early discovery.For swallowing not smooth or having patient's row gastroscopy as early as possible of foreign body sensation to find the early stage esophageal carcinoma or precancerous lesion.
Although the esophageal carcinoma has the variation background of gene as other the malignant tumor, relate to multifactor, multistage, polygenic variation accumulation and interactional complex process, on molecular level, relate to the change of numerous proto-oncogenes, antioncogene and protein.But long-term bad life or dietary habit may be the arch-criminals who causes the esophageal carcinoma to occur.Think at present, cause that the Related Risk Factors of the esophageal carcinoma mainly contains: feed is containing the more food (as liked pickling sauerkraut) of nitrosamines or the food that goes mouldy, like into scalding food (as high in Chaozhou-Shantou region human esophagus cancer sickness rate may with drink for a long time kung fu tea relevant), bad habit (as smoking, drink) etc. for a long time.China is Esophageal Cancer area, occupies the 4th of tumor mortality.Current Therapeutic Method is main mainly with operative treatment, and Combined with Radiotherapy or chemotherapy, can bring in various degree painful and worried to patient, and easily cause other complication in therapeutic process.
Summary of the invention:
Comprehensively above-mentioned, in order to overcome the deficiency of prior art problem, it is simple that the present invention has developed a kind of configuration, the Chinese medicine of the treatment esophageal carcinoma evident in efficacy.
The object of the present invention is achieved like this: a kind of Chinese medicine that is used for the treatment of the esophageal carcinoma, is prepared from by the medicine of following parts by weight: the Rhizoma Pinelliae of the Semen Impatientis of 6~9 parts by weight, the Mylabris of 0.5~1.5 parts by weight, 5~15 parts by weight, the Poria of 15~25 parts by weight, the Herba Dendrobii of 15~25 parts by weight, the Radix Glycyrrhizae of 5~15 parts by weight.
Technical scheme of the present invention can be achieved in that
Be used for the treatment of a Chinese medicine for the esophageal carcinoma, be prepared from by the medicine of following parts by weight: the Rhizoma Pinelliae of the Semen Impatientis of 7 parts by weight, the Mylabris of 1 parts by weight, 10 parts by weight, the Poria of 20 parts by weight, the Herba Dendrobii of 20 parts by weight, the Radix Glycyrrhizae of 10 parts by weight.
The present invention mixes each raw material, is ground into fine powder, directly take, and every day three times, each 1-2 gram, warm water takes.
The course for the treatment of: 30 days be a course for the treatment of, need take the 3-8 course for the treatment of.
Pharmacology of the present invention and literature basis are:
Semen Impatientis: acrid, bitter, warm, mild toxicity; Effect: clots absorbing sending down the abnormal ascending QI, hard masses softening and resolving.
Mylabris: pungent, warm, poisonous; Effect: antitumor , Po Disorder eliminating stagnation, counteracting toxic substances phagedenoma.
The Rhizoma Pinelliae: pungent, temperature; Poisonous; Effect: drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.
Poria: sweet, light, flat; Effect: eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming.
Herba Dendrobii: sweet, be slightly cold; Effect: reinforcing stomach reg fluid, nourishing YIN and clearing away heat.
Radix Glycyrrhizae: sweet, flat; Effect: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
Semen Impatientis, Mylabris hard masses softening and resolving in the present invention, the Rhizoma Pinelliae, Poria eliminating phlegm and lowering adverse QI stomach function regulating, Herba Dendrobii nourishing YIN and clearing away heat, Radix Glycyrrhizae heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription, all medicines have share the merit of heat-clearing and toxic substances removing, softening and eliminating sputum, regulating the stomach and sending down the abnormal ascending QI.
Beneficial effect of the present invention:
The present invention forms with pure traditional Chinese medicine, and scientific formulation is reasonable, and configuration is simple, has no side effect, and curative effect is short, and instant effect has effect of heat-clearing and toxic substances removing, softening and eliminating sputum, regulating the stomach and sending down the abnormal ascending QI.
The specific embodiment:
Below in conjunction with embodiment, the present invention is described in further details:
Embodiment 1: a kind of Chinese medicine that is used for the treatment of the esophageal carcinoma, is prepared from by the medicine of following weight grams: the Semen Impatientis of 7 grams, the Mylabris of 1 gram, the Rhizoma Pinelliae of 10 grams, the Poria of 20 grams, the Herba Dendrobii of 20 grams, the Radix Glycyrrhizae of 10 grams.
Embodiment 2: a kind of Chinese medicine that is used for the treatment of the esophageal carcinoma, is prepared from by the medicine of following weight grams: the Semen Impatientis of 9 grams, the Mylabris of 1.5 grams, the Rhizoma Pinelliae of 15 grams, the Poria of 25 grams, the Herba Dendrobii of 25 grams, the Radix Glycyrrhizae of 15 grams.
Embodiment 3: a kind of Chinese medicine that is used for the treatment of the esophageal carcinoma, is prepared from by the medicine of following weight grams: the Semen Impatientis of 6 grams, the Mylabris of 0.5 gram, the Rhizoma Pinelliae of 5 grams, the Poria of 15 grams, the Herba Dendrobii of 15 grams, the Radix Glycyrrhizae of 5 grams.
Embodiment 4: a kind of Chinese medicine that is used for the treatment of the esophageal carcinoma, is prepared from by the medicine of following weight grams: the Semen Impatientis of 8 grams, the Mylabris of 0.9 gram, the Rhizoma Pinelliae of 6 grams, the Poria of 23 grams, the Herba Dendrobii of 22 grams, the Radix Glycyrrhizae of 8 grams.
Chinese medicine in embodiment 1-4 mixes each raw material in the preparation, is ground into fine powder, directly takes, and every day three times, each 1-2 gram, takes with warm water.
The present invention is not limited to above-mentioned preferred forms, and other any or akin products identical with the present invention that anyone draws under enlightenment of the present invention, within all dropping on protection scope of the present invention.
The result of clinical observation of the present invention is as follows:
Criterion of therapeutical effect:
Cure: patient's transference cure, checks and reach arm's length standard.
Effective: patient's symptom makes moderate progress, but do not reach arm's length standard.
Invalid: through a period of time treatment, patient's symptom is without any improvement.
Curative effect of medication is observed situation:
Drug therapy 79 people of the present invention, healing person 58 people, responder 12 people, nonresponder 9 people, effective percentage 88%.
Model case:
Field: man, 53 years old, people from Puyang oilfield of Henan, the esophageal carcinoma is early stage, has foreign body sensation in esophagus, epigastrium pain, by here Drug therapy, one month takes effect, recovery from illness in four months.
Temperature certain: female, 51 years old, Henan flat-top recluse, the esophageal carcinoma is early stage, while swallowing, breastbone discomfort, has prickling-like pain, by here Drug therapy, one and a half months takes effect, five months recovery from illness.
Week certain: man, 46 years old, people from Weidong District, table mountain, esophageal carcinoma mid-term, carrying out property dysphagia, regurgitation of food, by here Drug therapy, two months take effect, recovery from illness in six months.
High certain: female, 42 years old, people from Dezhou, Shandong, esophageal carcinoma mid-term, many places therapeutic effect is all not obvious, by here Drug therapy, two months take effect, recovery from illness in six months.

Claims (2)

1. one kind is used for the treatment of the Chinese medicine of the esophageal carcinoma, it is characterized in that: the medicine by following parts by weight is prepared from: the Rhizoma Pinelliae of the Semen Impatientis of 6~9 parts by weight, the Mylabris of 0.5~1.5 parts by weight, 5~15 parts by weight, the Poria of 15~25 parts by weight, the Herba Dendrobii of 15~25 parts by weight, the Radix Glycyrrhizae of 5~15 parts by weight, its preparation method is that each raw material is mixed, and is ground into fine powder.
2. the Chinese medicine that is used for the treatment of the esophageal carcinoma according to claim 1, it is characterized in that: the medicine by following parts by weight is prepared from: the Rhizoma Pinelliae of the Semen Impatientis of 7 parts by weight, the Mylabris of 1 parts by weight, 10 parts by weight, the Poria of 20 parts by weight, the Herba Dendrobii of 20 parts by weight, the Radix Glycyrrhizae of 10 parts by weight, its preparation method is that each raw material is mixed, and is ground into fine powder.
CN201210231819.XA 2012-07-06 2012-07-06 Traditional Chinese medicine used for treating esophageal cancer Expired - Fee Related CN102716340B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210231819.XA CN102716340B (en) 2012-07-06 2012-07-06 Traditional Chinese medicine used for treating esophageal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210231819.XA CN102716340B (en) 2012-07-06 2012-07-06 Traditional Chinese medicine used for treating esophageal cancer

Publications (2)

Publication Number Publication Date
CN102716340A CN102716340A (en) 2012-10-10
CN102716340B true CN102716340B (en) 2014-05-28

Family

ID=46942294

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210231819.XA Expired - Fee Related CN102716340B (en) 2012-07-06 2012-07-06 Traditional Chinese medicine used for treating esophageal cancer

Country Status (1)

Country Link
CN (1) CN102716340B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1204522A (en) * 1997-07-08 1999-01-13 孙贤华 Chinese prescription medicine for treatment of digestive tract tumour and preparation method thereof
CN1410095A (en) * 2002-11-21 2003-04-16 杜仰恩 Chinese patent medicine for treating esophagus cancer
CN1537530A (en) * 2003-10-22 2004-10-20 力 刘 Unit dosage type compound cantharis acid powder-injection, and its prepn. method
CN1615845A (en) * 2003-11-16 2005-05-18 刘力 Unit dosage type norcantharidine acid or its derivative powder injection and its preparing method
CN101485799A (en) * 2009-02-20 2009-07-22 窦保民 Paste capable of dispelling pain and eliminating cancer
CN100574768C (en) * 2006-01-24 2009-12-30 山东轩竹医药科技有限公司 A kind of anticancer pharmaceutical composition and its production and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120020635A (en) * 2010-08-30 2012-03-08 주식회사한국전통의학연구소 Composition comprising tuckahoe for treatment of prostate cancer
KR20120020642A (en) * 2010-08-30 2012-03-08 주식회사한국전통의학연구소 Composition comprising licorice for treatment of prostate cancer

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1204522A (en) * 1997-07-08 1999-01-13 孙贤华 Chinese prescription medicine for treatment of digestive tract tumour and preparation method thereof
CN1410095A (en) * 2002-11-21 2003-04-16 杜仰恩 Chinese patent medicine for treating esophagus cancer
CN1537530A (en) * 2003-10-22 2004-10-20 力 刘 Unit dosage type compound cantharis acid powder-injection, and its prepn. method
CN1615845A (en) * 2003-11-16 2005-05-18 刘力 Unit dosage type norcantharidine acid or its derivative powder injection and its preparing method
CN100574768C (en) * 2006-01-24 2009-12-30 山东轩竹医药科技有限公司 A kind of anticancer pharmaceutical composition and its production and use
CN101485799A (en) * 2009-02-20 2009-07-22 窦保民 Paste capable of dispelling pain and eliminating cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
张洪亮等.食管癌.《新疆中医药》.2006,第24卷(第5期),126-128页,尤其是第128页左栏第4-5段、最后第1段.
王瑞平等.食管癌及其癌前病变中医治疗近况.《山东中医药大学学报》.1994,第18卷(第1期),第66-67页,尤其是第66页"1.2辨病专方治疗".
食管癌;张洪亮等;《新疆中医药》;20061231;第24卷(第5期);126-128页,尤其是第128页左栏第4-5段、最后第1段 *
食管癌及其癌前病变中医治疗近况;王瑞平等;《山东中医药大学学报》;19941231;第18卷(第1期);第66-67页,尤其是第66页"1.2辨病专方治疗" *

Also Published As

Publication number Publication date
CN102716340A (en) 2012-10-10

Similar Documents

Publication Publication Date Title
CN101869683B (en) Chinese medicinal composition for treating dry cough
CN102716340B (en) Traditional Chinese medicine used for treating esophageal cancer
Peng et al. Study on the application of Chinese patent drug and Chinese formula of Rabdosia rubescens
CN103100048A (en) Chinese herbal preparation for treating pharyngolaryngeal cancer and preparation method thereof
CN103610924A (en) Medicine for treating ulcerative colitis and preparation method thereof
CN102106999A (en) Chinese medicinal compound preparation for treating dysphagia due to stroke and preparation method thereof
CN103860823A (en) External pain-stopping tincture for cancer
US20200261532A1 (en) Chinese Medicine Composition for Treating Gastric Reflux
CN102366537A (en) Traditional Chinese medicine preparation for treating cough caused by lung dryness and preparation method thereof
CN102727854B (en) Traditional Chinese medicine for treatment of gastric cancer
CN103961629B (en) Traditional Chinese medicine for treating chronic gastritis
CN106668420A (en) American ginseng and pseudo-ginseng lung-protecting oral liquid and preparation method thereof
CN104127659A (en) Traditional Chinese medicine for treating chronic pharyngitis
CN104971096A (en) Traditional Chinese medicine preparation for treating emesis
CN104739942B (en) A kind of Chinese medicine for treating acute bronchitis
CN106236904A (en) A kind of Chinese medicine treating cystic polyp
CN105343432A (en) Stomach-nourishing pain-easing powder used for infants
CN104971109A (en) Traditional Chinese medicine used for treating cold fever
CN106237186B (en) It is a kind of to treat phthisical Chinese medicine
CN104998211A (en) Application of medicine composition to cervical spondylosis treatment
CN105435202A (en) Medicinal preparation for treating gastritis and purpose thereof
CN106421386A (en) Traditional Chinese medicine for curing esophagus cancer
CN104887823A (en) Traditional Chinese medicine composition for treating nasopharyngeal carcinoma and administration method thereof
CN111166838A (en) Miao-square ginseng-dendrobium tablet for treating acute and chronic gastritis and gastric ulcer and preparation method thereof
CN103417658A (en) Traditional Chinese medicine for treating chronic gastritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Jiang Fei

Inventor before: Xu Ruiqin

CB03 Change of inventor or designer information
TR01 Transfer of patent right

Effective date of registration: 20171012

Address after: 065000 Langfang City, Hebei province Guangyang District Rong Fu Road City insurance company dormitory 1 Building 2 unit 101 room

Patentee after: Jiang Fei

Address before: 467000 East worker Town, Weidong District, Henan, Pingdingshan

Patentee before: Xu Ruiqin

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140528

Termination date: 20180706

CF01 Termination of patent right due to non-payment of annual fee